XMD17 109
|
|
|
- CAS番号.
- 1435488-37-1
- 化学名:
- 别名:
- 英語名:
- XMD17 109
- 英語别名:
- CS-1288;XMD17-109;XMD17 109;XMD17 109;XMD17109;11-Cyclopentyl-2-[2-ethoxy-4-[4-(4-methylpiperazin-1-yl)piperidine-1-carbonyl]anilino]-5-methylpyrimido[4,5-b][1,4]benzodiazepin-6-one;11-Cyclopentyl-2-[[2-ethoxy-4-[[4-(4-methyl-1-piperazinyl)-1-piperidinyl]carbonyl]phenyl]amino]-5,11-dihydro-5-methyl-6H-pyrimido[4,5-b][1,4]benzodiazepin-6-one;6H-Pyrimido[4,5-b][1,4]benzodiazepin-6-one, 11-cyclopentyl-2-[[2-ethoxy-4-[[4-(4-methyl-1-piperazinyl)-1-piperidinyl]carbonyl]phenyl]amino]-5,11-dihydro-5-methyl-;11-Cyclopentyl-2-[[2-ethoxy-4-[[4-(4-methyl-1-piperazinyl)-1-piperidinyl]carbonyl]phenyl]amino]-5,11-dihydro-5-methyl-6H-pyrimido[4,5-b][1,4]benzodiazepin-6-one XMD17-109
- CBNumber:
- CB62666703
- 化学式:
- C36H46N8O3
- 分子量:
- 638.8
- MOL File:
- 1435488-37-1.mol
- MSDS File:
- SDS
|
XMD17 109 物理性質
- 貯蔵温度 :
- -20°C
- 溶解性:
- ≥31.95 mg/mL in DMSO; insoluble in H2O; ≥86.6 mg/mL in EtOH
- 外見 :
- 粉
- 色:
- 白からベージュ
XMD17 109 価格
もっと(4)
| メーカー |
製品番号 |
製品説明 |
CAS番号 |
包装 |
価格 |
更新時間 |
購入 |
|
富士フイルム和光純薬株式会社(wako)
|
W01TOC5393 |
ERK5-IN-1 |
1435488-37-1 |
10mg |
￥96000 |
2024-03-01 |
購入 |
|
富士フイルム和光純薬株式会社(wako)
|
W01TOC5393 |
ERK5-IN-1 |
1435488-37-1 |
50mg |
￥403000 |
2024-03-01 |
購入 |
|
Sigma-Aldrich Japan
|
SML1753 |
≥98% (HPLC)
XMD17-109 ≥98% (HPLC) |
1435488-37-1 |
5mg |
￥29200 |
2024-03-01 |
購入 |
|
Sigma-Aldrich Japan
|
SML1753 |
≥98% (HPLC)
XMD17-109 ≥98% (HPLC) |
1435488-37-1 |
25mg |
￥72880 |
2021-03-23 |
購入 |
XMD17 109 化学特性,用途語,生産方法
使用
ERK5-IN-1 is a potent selective ERK5 inhibitor, inhibiting EGFR-induced ERK5 autophosphorylation and ERK5 enzymatic activity. Orally bioavailable.
XMD17 109 上流と下流の製品情報
原材料
準備製品
XMD17 109 生産企業
Global( 83)Suppliers
1435488-37-1()キーワード:
5-{[2-メトキシ-4-(4-メチルピペラジン-1-イル)フェニル]アミノ}-2,9-ジメチル-2,4,6,9-テトラアザトリシクロ[9.4.0.03,8]ペンタデカ-1(15),3,5,7,11,13-ヘキサエン-10-オン
XMD8-92
- 1435488-37-1
- XMD17 109
- XMD17-109
- 11-Cyclopentyl-2-[[2-ethoxy-4-[[4-(4-methyl-1-piperazinyl)-1-piperidinyl]carbonyl]phenyl]amino]-5,11-dihydro-5-methyl-6H-pyrimido[4,5-b][1,4]benzodiazepin-6-one
- 11-Cyclopentyl-2-[[2-ethoxy-4-[[4-(4-methyl-1-piperazinyl)-1-piperidinyl]carbonyl]phenyl]amino]-5,11-dihydro-5-methyl-6H-pyrimido[4,5-b][1,4]benzodiazepin-6-one XMD17-109
- XMD17 109;XMD17109
- CS-1288
- 6H-Pyrimido[4,5-b][1,4]benzodiazepin-6-one, 11-cyclopentyl-2-[[2-ethoxy-4-[[4-(4-methyl-1-piperazinyl)-1-piperidinyl]carbonyl]phenyl]amino]-5,11-dihydro-5-methyl-
- 11-Cyclopentyl-2-[2-ethoxy-4-[4-(4-methylpiperazin-1-yl)piperidine-1-carbonyl]anilino]-5-methylpyrimido[4,5-b][1,4]benzodiazepin-6-one